EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+5.81%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$947M
AUM Growth
+$947M
(-15%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-14.16%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
77
New
15
Increased
20
Reduced
27
Closed
7
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$26.8M |
| 2 |
HCA Healthcare
HCA
|
$16M |
| 3 |
Bio-Techne
TECH
|
$12.6M |
| 4 |
Krystal Biotech
KRYS
|
$12.5M |
| 5 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$12.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$42.8M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.4M |
| 3 |
GSK
GSK
|
$30.6M |
| 4 |
Natera
NTRA
|
$19.8M |
| 5 |
AMED
Amedisys
AMED
|
$16.5M |
Sector Composition
| 1 | Healthcare | 98.52% |
| 2 | Communication Services | 0.83% |
| 3 | Financials | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $117M | 9.82% | 2,413,787 -405,983 | -14% | -$19.8M |
|
|
2
GSK
GSK
$79.9B
| $104M | 8.68% | 2,881,012 -850,487 | -23% | -$30.6M |
|
3
Teva Pharmaceuticals
TEVA
$21.1B
| $57.7M | 4.83% | 7,668,044 +1,473,472 | +24% | +$11.1M |
|
4
United Therapeutics
UTHR
$13.8B
| $57.5M | 4.81% | 260,398 +38,291 | +17% | +$8.45M |
|
|
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $48.9M | 4.09% | 475,310 -343,814 | -42% | -$35.4M |
|
6
Syndax Pharmaceuticals
SNDX
$1.41B
| $45.8M | 3.83% | 2,189,732 -19,325 | -0.9% | -$404K |
|
7
Community Health Systems
CYH
$387M
| $32M | 2.68% | 7,277,856 -1,804,449 | -20% | -$7.94M |
|
|
8
Bio-Techne
TECH
$8.5B
| $28M | 2.34% | 342,637 +153,978 | +82% | +$12.6M |
|
9
Vera Therapeutics
VERA
$1.38B
| $27.9M | 2.34% | 1,740,951 -47,578 | -3% | -$764K |
|
|
10
Inspire Medical Systems
INSP
$2.77B
| $26.8M | 2.24% | +82,445 | New | +$26.8M |
|
11
Celldex Therapeutics
CLDX
$1.47B
| $26.7M | 2.23% | 785,740 +96,064 | +14% | +$3.26M |
|
12
Danaher
DHR
$147B
| $24.8M | 2.08% | 103,345 -45,340 | -30% | -$10.9M |
|
|
13
HCA Healthcare
HCA
$94.5B
| $24.5M | 2.05% | 80,725 +52,816 | +189% | +$16M |
|
14
Illumina
ILMN
$15.8B
| $23.3M | 1.94% | 124,052 -46,485 | -27% | -$8.72M |
|
15
Icon
ICLR
$13.8B
| $17.9M | 1.5% | 71,726 -5,062 | -7% | -$1.27M |
|
16
BioCryst Pharmaceuticals
BCRX
$1.74B
| $16.7M | 1.4% | 2,372,113 -2,148,611 | -48% | -$15.1M |
|
17
Amneal Pharmaceuticals
AMRX
$3B
| $16.3M | 1.36% | 5,265,251 +82,205 | +2% | +$255K |
|
|
CTLT
18
DELISTED
CATALENT, INC.
CTLT
| $15.5M | 1.29% | 356,875 -216,734 | -38% | -$9.4M |
|
19
Seres Therapeutics
MCRB
$166M
| $14.7M | 1.23% | 3,076,756 +540,091 | +21% | +$2.59M |
|
|
20
Krystal Biotech
KRYS
$4.27B
| $12.5M | 1.05% | +106,465 | New | +$12.5M |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| $12.5M | 1.04% | 10,502,109 -4,110,648 | -28% | -$4.89M |
|
|
ABCM
22
DELISTED
Abcam plc American Depositary Shares
ABCM
| $12.2M | 1.02% | +499,394 | New | +$12.2M |
|
23
Centene
CNC
$14.3B
| $10.3M | 0.86% | 152,733 -135,693 | -47% | -$9.15M |
|
24
Ionis Pharmaceuticals
IONS
$6.79B
| $9.91M | 0.83% | 241,572 -61,797 | -20% | -$2.54M |
|
25
Vaxcyte
PCVX
$4B
| $9.77M | 0.82% | 195,691 -103,359 | -35% | -$5.16M |
|